Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2006
12/07/2006US20060276622 Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
12/07/2006US20060276621 Glycosylated specificity exchangers
12/07/2006US20060276547 Methods of treating cancer with HDAC inhibitors
12/07/2006US20060276493 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication
12/07/2006US20060276439 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
12/07/2006US20060276427 Regulation of endogenous gene expression in cells using zinc finger proteins
12/07/2006US20060276426 Human peroxisome proliferator activated receptor gamma (PPARgamma) gene regulatory sequences and uses therefor
12/07/2006US20060276419 Combined use of ribavirin and interferon beta in demyelinating diseases
12/07/2006US20060276416 Methods and compositions for treating flushing and drug induced weight gain
12/07/2006US20060276410 Compounds and methods for selective inhibition of dipeptidyl peptidase-iv
12/07/2006US20060276409 N-Hydroxy-N-(1-(2-carbamoylalkylaminocarbonyl)ethyl)formamides: [(Formyl-hydroxy-amino)-methyl]-3-cyclopentyl-propionic acid (1-dimethyl-carbamoyl-2,2-dimethyl-propyl)-amide; bacterial polypeptide deformylase inhibitors
12/07/2006US20060276408 Thrombin inhibitors; protease inhibition, kinase inhibition, CAAX inhibition, interference with peptides binding to SH2 domains and inhibition of MCH-I and/or MHC II presentation of peptides to T cell receptors
12/07/2006US20060276407 Methods of treating hepatitis C virus
12/07/2006US20060276406 Methods of treating hepatitis C virus
12/07/2006US20060276405 Methods for treating hepatitis C
12/07/2006US20060276404 Medicaments and methods combining a HCV protease inhibitor and an AKR competitor
12/07/2006US20060276403 Agonist polypeptide of receptor for ZOT and zonulin
12/07/2006US20060276402 Synthetic peptide inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4
12/07/2006US20060276401 Polypeptides useful for appetite suppression
12/07/2006US20060276400 Modulation of cholesteryl ester transfer protein (CETP) activity
12/07/2006US20060276399 Peptide antagonists of zonulin and methods for use of the same
12/07/2006US20060276398 Combined use of factor VII polypeptides and factor VIII polypeptides
12/07/2006US20060276397 Crystallization of IGF-1
12/07/2006US20060276396 Stimulating insulin synthesis and release, enhancing adipose, muscle or liver tissue sensitivity towards insulin uptake, stimulating glucose uptake, slowing digestive process, or blocking the secretion of glucagon; glucagon-like protein
12/07/2006US20060276395 Pharmaceutical Compositions of Adiponectin Variants and Methods of Storage
12/07/2006US20060276394 Methods and compositions for treating neurological disorders
12/07/2006US20060276393 Novel compositions for preventing and treating neurodegenerative and blood coagulation disorders
12/07/2006US20060276392 Treatments employing neuronal exocytosis-inhibiting peptides
12/07/2006US20060276391 Use of compounds that interfere with the Hedgehog signaling pathway for the manufacture of a medicament for preventing, inhibiting, and/or reversing ocular diseases related with ocular neovascularization
12/07/2006US20060276390 Combined treatments comprising synthetic peptide copolymers for preventing graft rejection
12/07/2006US20060276389 Fugetactic proteins, compositions and methods of use
12/07/2006US20060276388 Hip/pap polypeptide compositions for use in liver regeneration and for the prevention of liver failure
12/07/2006US20060276387 Method of controlling transcription insulin gene
12/07/2006US20060276386 Use of substances inhibiting the association of said protein with ubiquitin c-terminal hydrolase for altering cellular responses to tgf-beta or bmp
12/07/2006US20060276385 Anti-inflammatory agents and methods of their use
12/07/2006US20060276384 Peptides and medicinal compositions containing the same
12/07/2006US20060276383 Full length polynucleotide coding chicken type II collagen and the use of it
12/07/2006US20060276382 Administering a natriuretic hormone peptide (NHP), or a nucleic acid sequence encoding NHP; respiratory system disorders
12/07/2006US20060276381 Remedy for diabetes
12/07/2006US20060276380 Gomesin has 18 amino acid residues, configured as a hairpin structure consisting of two anti-parallel beta-folded sheets joined by a beta turn, containing four invariable residues of cysteine forming two disulfide bridges, configurable as a cyclic chain with open or closed ends; low hemolytic activity
12/07/2006US20060276379 Binding peptides specific for the extracellular domain of ErbB2 and uses therefor
12/07/2006US20060276378 Methods and pharmaceutical compositions for treating sepsis
12/07/2006US20060276377 Factor VII or VIIa Polypeptide Variants
12/07/2006US20060276376 Increasing functional glycosylation of alpha-dystroglycan in the treatment of muscle degeneration
12/07/2006US20060276375 Gpi anchored glycoprotein aca as a novel tumor marker
12/07/2006US20060276374 Use of an agent that restores tissue perfusion and oxygenation
12/07/2006US20060276373 Neuroprotective complex for treatment of cerebral ischemia and injury
12/07/2006US20060276372 Carotenoids, carotenoid analogs, or carotenoid derivatives for the treatment of proliferative disorders
12/07/2006US20060275903 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
12/07/2006US20060275900 Methods for in vitro expansion and transdifferentiation of human pancreatic acinar cells into insulin-producing cells
12/07/2006US20060275898 Compositions and Methods for Making Embryonic Stem Cells
12/07/2006US20060275870 Novel G-protein coupled receptors and uses therefor
12/07/2006US20060275868 Fusion proteins comprising tumor necrosis factor receptor
12/07/2006US20060275865 Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy
12/07/2006US20060275848 Diagnosis and treatment of microbacterial infections
12/07/2006US20060275832 Methods of screening cyclic peptides and identifying targets therefor
12/07/2006US20060275803 Rat and mouse members of the CRISP family of genes
12/07/2006US20060275797 Use of agents which inhibit connective tissue growth factor (CTGF) binding and signaling via the TrkA/p75NTR receptor complex for the prevention and treatment of CTGF-mediated ocular disorders
12/07/2006US20060275764 Method for determining predisposition to manifestation of immune system related diseases
12/07/2006US20060275758 Use of pp2a phosphatase modulators in the treatment of mental disorders
12/07/2006US20060275755 Novel nucleic acids and polypeptides related to a guanine exchange factor of rho gtpase
12/07/2006US20060275750 Bioreactive agents
12/07/2006US20060275748 which promote strand transfer activity of viral integrase, such as HIV integrase; screening molecules for antiviral activity comprising exposing the molecules to epithelial growth factors, fragments or nucleotides codes and determining the ability to modulate the interaction with retroviral integrases
12/07/2006US20060275370 Method and compositions for treatment of epithelial damage
12/07/2006US20060275366 Controlled-release formulation
12/07/2006US20060275358 Self-microemulsifying dosage forms of low solubility active ingredients such as co-enzyme Q10
12/07/2006US20060275353 Stable topical drug delivery compositions
12/07/2006US20060275351 Topical oligopeptide delivery system
12/07/2006US20060275350 Skin dressings containing oxidoreductase enzyme
12/07/2006US20060275345 Collagen hydrolysate
12/07/2006US20060275338 Intravascular prosthesis containing an inhibitor of smooth muscle cell proliferation such as fibulin-5 (UP50) and a growth factor such as vascular endothelial growth factor (VEGF); stents; restenosis
12/07/2006US20060275329 Flavin protein of trypanosoma cruzi, method of screening vermicide with the use of the same and diagnostic
12/07/2006US20060275328 Instrument for inducing cytokine and method of inducing cytokine
12/07/2006US20060275327 In vivo modulation of neuronal transport
12/07/2006US20060275326 Administering a botulinum toxin
12/07/2006US20060275325 Method for treating allodynia by peripheral administration of a neurotoxin
12/07/2006US20060275319 Saccharomyces cerevisiae yeast strain with functional expression of a GLUT transporter
12/07/2006US20060275317 Vaccine compositions for prevention of chronic and infectious diseases
12/07/2006US20060275316 Modulation of cxcr4 and related methods and compositions
12/07/2006US20060275313 Therapeutic and diagnostic agents
12/07/2006US20060275312 Molecule
12/07/2006US20060275308 Combination of gallium compounds with nonchemotherapeutic anticancer agents in the treatment of neoplasia
12/07/2006US20060275304 Novel tumor antigen useful in diagnosis and therapy of prostate and colon cancer
12/07/2006US20060275303 Modulating angiogenesis using LL-37/HCAP-18
12/07/2006US20060275299 Use of protein tyrosine phosphatase inhibitors for prevention and/or treatment of cancer
12/07/2006US20060275298 Antagonist of Th-1 immuneresponse inducing cytokine for the treatment of autoimmune diseases
12/07/2006US20060275297 Antigen binding fragment binds to denatured polypeptide which chemoattracts peripheral blood monocytes or T-cells; immunizing animal
12/07/2006US20060275295 Activity of THAP-family chemokine-binding domains
12/07/2006US20060275293 Splice variant of the human pituitary growth hormone
12/07/2006US20060275290 Active or passive immunization against proapoptotic neurotrophins for the treatment and/or prevention of neurodegenerative diseases
12/07/2006US20060275287 Scroll compressor
12/07/2006US20060275284 Combination therapy for treatment of autoimmune diseases using b-cell depleting/immunoregulatory antibody combination
12/07/2006US20060275280 Contacting a latent myostatin complex comprising a myostatin pro peptide and a myostatin C-terminal fragment, and a metalloprotease that can cleave the myostatin pro peptide, with an agent that increases or decreases proteolytic cleavage of the pro peptide by the metalloprotease
12/07/2006US20060275279 Methods for dissolving cystine stones and reducing cystine in urine
12/07/2006US20060275278 Method and ophthalmic formulation for eye protection or treatment
12/07/2006US20060275277 Use of coagulation proteins to lyse clots
12/07/2006US20060275274 Use of saposin-related proteins for preventing and treating obesity, diabetes and/or metabolic syndrome
12/07/2006US20060275267 Nucleic acids encoding inactive variants of human telomerase
12/07/2006US20060275266 Tripeptide of FcyRIIA
12/07/2006US20060275263 Cell proliferation inhibitory proteins and polynucleotides, antisense polynucleotides to the polynucleotides, cell proliferation inhibitors using the foregoing, cancer diagnostic agents, cancer therapeutic agents and compositions for gene therapy